# L_2023073EN.01000101.xml

| 10.3.2023 | EN | Official Journal of the European Union | L 73/1 |
| --- | --- | --- | --- |

10.3.2023

EN

Official Journal of the European Union

L 73/1

---

COMMISSION IMPLEMENTING REGULATION (EU) 2023/543

of 9 March 2023

amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 19 thereof,

Whereas:

| (1) | Commission Implementing Regulation (EU) No 686/2012 (2) allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation. |
| --- | --- |

(1)

Commission Implementing Regulation (EU) No 686/2012 (2) allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation.

| (2) | That allocation should be made in a way that ensures a balance between Member States as regards the distribution of the responsibilities and the work. |
| --- | --- |

(2)

That allocation should be made in a way that ensures a balance between Member States as regards the distribution of the responsibilities and the work.

| (3) | Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly. |
| --- | --- |

(3)

Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.

| (4) | The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, |
| --- | --- |

(4)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 9 March 2023.

For the Commission

The President

Ursula VON DER LEYEN

---

(1)  
  OJ L 309, 24.11.2009, p. 1.

1

(2)  Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances (OJ L 200, 27.7.2012, p. 5).

2

---

ANNEX

In the Annex to Implementing Regulation (EU) No 686/2012, the following Part E is added:

‘PART E

Allocation of the evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035

| Active substance | Rapporteur Member State | Co-rapporteur Member State |
| --- | --- | --- |
| 1-methylcyclopropene | DE | EL |
| 2,4-D | DE | EL |
| 2,4-DB | EL | IE |
| ABE-IT 56 | FR | PT |
| Acetamiprid | DE | ES |
| Acibenzolar-S-methyl | ES | BE |
| Ampelomyces quisqualis strain AQ10 | SE | NL |
| Bacillus amyloliquefaciens strain FZB24 | DE | AT |
| Bacillus subtilis strain IAB/BS03 | ES | AT |
| Beauveria bassiana strain 203 | DK | NL |
| Beauveria bassiana strain IMI389521 | SE | NL |
| Beauveria bassiana strain PPRI 5339 | SE | NL |
| Benzoic acid | HU | CZ |
| Carfentrazone-ethyl | FR | DE |
| Carvone | IT | NL |
| Cerevisane | ES | DE |
| Clonostachys rosea strain J1446 | HU | AT |
| Coniothyrium minitans strain CON/M/91-08 | AT | EE |
| COS-OGA | FR | HR |
| Cyhalofop-butyl | CZ | BE |
| Cypermethrin | CZ | DE |
| Dimethenamid-P | BE | DE |
| Ethofumesate | AT | FI |
| Fenhexamid | BE | CZ |
| Ferric phosphate | PL | DK |
| Ferric pyrophosphate | CZ | FR |
| Flazasulfuron | ES | PL |
| Florasulam | CZ | FR |
| Florpyrauxifen-benzyl | FR | IT |
| Flutianil | DE | EL |
| Foramsulfuron | FR | SK |
| Forchlorfenuron | ES | BE |
| Iodosulfuron | BE | FR |
| Iprovalicarb | SE | LV |
| Isaria fumosorosea strain Apopka 97 | NL | AT |
| Isoxaflutole | SE | BE |
| Laminarin | EL | FR |
| Lavandulyl senecioate | SE | NL |
| Maleic hydrazide | SI | IT |
| Mefentrifluconazole | ES | FR |
| Mesosulfuron | PL | SE |
| Mesotrione | NL | SK |
| Metalaxyl-M | DE | EL |
| Mild Pepino Mosaic Virus isolate VC 1 | FR | DE |
| Mild Pepino Mosaic Virus isolate VX 1 | FR | DE |
| Pasteuria nishizawae Pn1 | NL | DK |
| Pepino mosaic virus strain CH2 isolate 1906 | FI | BE |
| Pethoxamid | AT | FR |
| Phlebiopsis gigantea strain FOC PG 410.3 | EE | FI |
| Phlebiopsis gigantea strain VRA 1835 | EE | FI |
| Phlebiopsis gigantea strain VRA 1984 | EE | FI |
| Picolinafen | LT | IT |
| Propoxycarbazone | SE | BE |
| Pyraflufen-ethyl | DE | FR |
| Pyridate | AT | DE |
| Pyriproxyfen | ES | BE |
| Saccharomyces cerevisiae strain LAS02 | EL | AT |
| Silthiofam | NL | IE |
| Sodium hydrogen carbonate | AT | FR |
| Sulfosulfuron | IE | SE |
| Thiabendazole | NO | ES |
| Thifensulfuron-methyl | FR | DK |
| Tolclofos-methyl | FI | SE |
| Tribenuron | FR | SE |
| Trichoderma atroviride strain SC1 | SI | NL |
| Trifloxystrobin | HR | DE |
| Verticillium albo-atrum strain WCS850 | NL | SE |
| Zoxamide | BE | PL’ |

Active substance

Rapporteur Member State

Co-rapporteur Member State

1-methylcyclopropene

DE

EL

2,4-D

DE

EL

2,4-DB

EL

IE

ABE-IT 56

FR

PT

Acetamiprid

DE

ES

Acibenzolar-S-methyl

ES

BE

Ampelomyces quisqualis strain AQ10

SE

NL

Bacillus amyloliquefaciens strain FZB24

DE

AT

Bacillus subtilis strain IAB/BS03

ES

AT

Beauveria bassiana strain 203

DK

NL

Beauveria bassiana strain IMI389521

SE

NL

Beauveria bassiana strain PPRI 5339

SE

NL

Benzoic acid

HU

CZ

Carfentrazone-ethyl

FR

DE

Carvone

IT

NL

Cerevisane

ES

DE

Clonostachys rosea strain J1446

HU

AT

Coniothyrium minitans strain CON/M/91-08

AT

EE

COS-OGA

FR

HR

Cyhalofop-butyl

CZ

BE

Cypermethrin

CZ

DE

Dimethenamid-P

BE

DE

Ethofumesate

AT

FI

Fenhexamid

BE

CZ

Ferric phosphate

PL

DK

Ferric pyrophosphate

CZ

FR

Flazasulfuron

ES

PL

Florasulam

CZ

FR

Florpyrauxifen-benzyl

FR

IT

Flutianil

DE

EL

Foramsulfuron

FR

SK

Forchlorfenuron

ES

BE

Iodosulfuron

BE

FR

Iprovalicarb

SE

LV

Isaria fumosorosea strain Apopka 97

NL

AT

Isoxaflutole

SE

BE

Laminarin

EL

FR

Lavandulyl senecioate

SE

NL

Maleic hydrazide

SI

IT

Mefentrifluconazole

ES

FR

Mesosulfuron

PL

SE

Mesotrione

NL

SK

Metalaxyl-M

DE

EL

Mild Pepino Mosaic Virus isolate VC 1

FR

DE

Mild Pepino Mosaic Virus isolate VX 1

FR

DE

Pasteuria nishizawae Pn1

NL

DK

Pepino mosaic virus strain CH2 isolate 1906

FI

BE

Pethoxamid

AT

FR

Phlebiopsis gigantea strain FOC PG 410.3

EE

FI

Phlebiopsis gigantea strain VRA 1835

EE

FI

Phlebiopsis gigantea strain VRA 1984

EE

FI

Picolinafen

LT

IT

Propoxycarbazone

SE

BE

Pyraflufen-ethyl

DE

FR

Pyridate

AT

DE

Pyriproxyfen

ES

BE

Saccharomyces cerevisiae strain LAS02

EL

AT

Silthiofam

NL

IE

Sodium hydrogen carbonate

AT

FR

Sulfosulfuron

IE

SE

Thiabendazole

NO

ES

Thifensulfuron-methyl

FR

DK

Tolclofos-methyl

FI

SE

Tribenuron

FR

SE

Trichoderma atroviride strain SC1

SI

NL

Trifloxystrobin

HR

DE

Verticillium albo-atrum strain WCS850

NL

SE

Zoxamide

BE

PL’

---